Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP73243.RAHgaV0o64T1pqchu1LxT9R3sro0T-SowGFo1Huh2W8jo130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP73243.RAHgaV0o64T1pqchu1LxT9R3sro0T-SowGFo1Huh2W8jo130_assertion type Assertion NP73243.RAHgaV0o64T1pqchu1LxT9R3sro0T-SowGFo1Huh2W8jo130_head.
- NP73243.RAHgaV0o64T1pqchu1LxT9R3sro0T-SowGFo1Huh2W8jo130_assertion description "[Although there was a tendency toward an increased number of the genotype TT of the 5-HT6 receptor polymorphism in AD patients when compared to controls (2.8% vs. 1.3%), neither this nor the 5-HT2A promoter polymorphism showed significant differences in their genotypic or allelic distribution among patients and controls.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP73243.RAHgaV0o64T1pqchu1LxT9R3sro0T-SowGFo1Huh2W8jo130_provenance.
- NP73243.RAHgaV0o64T1pqchu1LxT9R3sro0T-SowGFo1Huh2W8jo130_assertion evidence source_evidence_literature NP73243.RAHgaV0o64T1pqchu1LxT9R3sro0T-SowGFo1Huh2W8jo130_provenance.
- NP73243.RAHgaV0o64T1pqchu1LxT9R3sro0T-SowGFo1Huh2W8jo130_assertion SIO_000772 11725820 NP73243.RAHgaV0o64T1pqchu1LxT9R3sro0T-SowGFo1Huh2W8jo130_provenance.
- NP73243.RAHgaV0o64T1pqchu1LxT9R3sro0T-SowGFo1Huh2W8jo130_assertion wasDerivedFrom gad-20150221 NP73243.RAHgaV0o64T1pqchu1LxT9R3sro0T-SowGFo1Huh2W8jo130_provenance.
- NP73243.RAHgaV0o64T1pqchu1LxT9R3sro0T-SowGFo1Huh2W8jo130_assertion wasGeneratedBy ECO_0000203 NP73243.RAHgaV0o64T1pqchu1LxT9R3sro0T-SowGFo1Huh2W8jo130_provenance.